SBC Medical Group Holdings (SBCWW) Cost of Revenue (2023 - 2026)

SBC Medical Group Holdings (SBCWW) has 3 years of Cost of Revenue data on file, last reported at $10.6 million in Q4 2025.

• Quarterly Cost of Revenue rose 0.85% year-over-year to $10.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $46.3 million (down 6.16% YoY) and the FY2025 annual result came in at $46.3 million, down 6.16% from the prior year.
• Cost of Revenue eased to $10.6 million in Q4 2025, from $12.7 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $19.0 million in Q4 2023 to a low of $9.6 million in Q1 2025.
• A 3-year average of $12.8 million and a median of $13.0 million in 2025 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2024 — Cost of Revenue sank 44.43% — and 2025, when it rose 29.41%.
• Tracing SBCWW's Cost of Revenue over 3 years: stood at $19.0 million in 2023, then slumped by 44.43% to $10.5 million in 2024, then climbed by 0.85% to $10.6 million in 2025.
• The last three Cost of Revenue figures came in at $10.6 million (Q4 2025), $12.7 million (Q3 2025), and $13.3 million (Q2 2025), per Business Quant data.